世界の乾癬性関節炎治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Psoriatic Arthritis Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z4855 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、乾癬性関節炎治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（非ステロイド性抗炎症薬、疾患修飾性抗リウマチ薬、生物学的薬剤、酵素阻害剤）、用途別市場規模（病院、診療所、研究所）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・乾癬性関節炎治療薬の市場動向 ・企業の競争状況、市場シェア ・乾癬性関節炎治療薬の種類別市場規模（非ステロイド性抗炎症薬、疾患修飾性抗リウマチ薬、生物学的薬剤、酵素阻害剤） ・乾癬性関節炎治療薬の用途別市場規模（病院、診療所、研究所） ・乾癬性関節炎治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・乾癬性関節炎治療薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・乾癬性関節炎治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・乾癬性関節炎治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・乾癬性関節炎治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Pfizer、Bayer、Novartis、Abbott Laboratories、Sanofi、Bristol-Myers Squibb、Janssen Biotech、Amgen、UCB、AbbVie） ・結論

Psoriatic arthritis is a long-term inflammatory arthritis that occurs in people affected by the autoimmune disease psoriasis.
The global psoriatic arthritis therapeutics market is expected to grow rapidly over the forecast period owing to the increasing prevalence rate of psoriatic arthritis.

Market Analysis and Insights: Global Psoriatic Arthritis Therapeutics Market
The global Psoriatic Arthritis Therapeutics market size is projected to reach US$ 11750 million by 2026, from US$ 6400 million in 2019, at a CAGR of 9.0% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Psoriatic Arthritis Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Psoriatic Arthritis Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Psoriatic Arthritis Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Psoriatic Arthritis Therapeutics market.

Global Psoriatic Arthritis Therapeutics Scope and Market Size
Psoriatic Arthritis Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Psoriatic Arthritis Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Nonsteroidal Anti-Inflammatory Drug
Disease-Modifying Antirheumatic Drug
Biologic Drug
Enzyme Inhibitor

Segment by Application
Hospitals
Clinics
Research Labs

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
Bayer
Novartis
Abbott Laboratories
Sanofi
Bristol-Myers Squibb
Janssen Biotech
Amgen
UCB

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Psoriatic Arthritis Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Nonsteroidal Anti-Inflammatory Drug
1.2.3 Disease-Modifying Antirheumatic Drug
1.2.4 Biologic Drug
1.2.5 Enzyme Inhibitor
1.3 Market by Application
1.3.1 Global Psoriatic Arthritis Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Research Labs
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Psoriatic Arthritis Therapeutics Market Perspective (2016-2027)
2.2 Psoriatic Arthritis Therapeutics Growth Trends by Regions
2.2.1 Psoriatic Arthritis Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Psoriatic Arthritis Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Psoriatic Arthritis Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Psoriatic Arthritis Therapeutics Industry Dynamic
2.3.1 Psoriatic Arthritis Therapeutics Market Trends
2.3.2 Psoriatic Arthritis Therapeutics Market Drivers
2.3.3 Psoriatic Arthritis Therapeutics Market Challenges
2.3.4 Psoriatic Arthritis Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Psoriatic Arthritis Therapeutics Players by Revenue
3.1.1 Global Top Psoriatic Arthritis Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Psoriatic Arthritis Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Psoriatic Arthritis Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Psoriatic Arthritis Therapeutics Revenue
3.4 Global Psoriatic Arthritis Therapeutics Market Concentration Ratio
3.4.1 Global Psoriatic Arthritis Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Psoriatic Arthritis Therapeutics Revenue in 2020
3.5 Psoriatic Arthritis Therapeutics Key Players Head office and Area Served
3.6 Key Players Psoriatic Arthritis Therapeutics Product Solution and Service
3.7 Date of Enter into Psoriatic Arthritis Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Psoriatic Arthritis Therapeutics Breakdown Data by Type
4.1 Global Psoriatic Arthritis Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Psoriatic Arthritis Therapeutics Forecasted Market Size by Type (2022-2027)

5 Psoriatic Arthritis Therapeutics Breakdown Data by Application
5.1 Global Psoriatic Arthritis Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Psoriatic Arthritis Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Psoriatic Arthritis Therapeutics Market Size (2016-2027)
6.2 North America Psoriatic Arthritis Therapeutics Market Size by Type
6.2.1 North America Psoriatic Arthritis Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Psoriatic Arthritis Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Psoriatic Arthritis Therapeutics Market Size by Type (2016-2027)
6.3 North America Psoriatic Arthritis Therapeutics Market Size by Application
6.3.1 North America Psoriatic Arthritis Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Psoriatic Arthritis Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Psoriatic Arthritis Therapeutics Market Size by Application (2016-2027)
6.4 North America Psoriatic Arthritis Therapeutics Market Size by Country
6.4.1 North America Psoriatic Arthritis Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Psoriatic Arthritis Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Psoriatic Arthritis Therapeutics Market Size (2016-2027)
7.2 Europe Psoriatic Arthritis Therapeutics Market Size by Type
7.2.1 Europe Psoriatic Arthritis Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Psoriatic Arthritis Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Psoriatic Arthritis Therapeutics Market Size by Type (2016-2027)
7.3 Europe Psoriatic Arthritis Therapeutics Market Size by Application
7.3.1 Europe Psoriatic Arthritis Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Psoriatic Arthritis Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Psoriatic Arthritis Therapeutics Market Size by Application (2016-2027)
7.4 Europe Psoriatic Arthritis Therapeutics Market Size by Country
7.4.1 Europe Psoriatic Arthritis Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Psoriatic Arthritis Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Psoriatic Arthritis Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Psoriatic Arthritis Therapeutics Market Size by Type
8.2.1 Asia-Pacific Psoriatic Arthritis Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Psoriatic Arthritis Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Psoriatic Arthritis Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Psoriatic Arthritis Therapeutics Market Size by Application
8.3.1 Asia-Pacific Psoriatic Arthritis Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Psoriatic Arthritis Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Psoriatic Arthritis Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Psoriatic Arthritis Therapeutics Market Size by Region
8.4.1 Asia-Pacific Psoriatic Arthritis Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Psoriatic Arthritis Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Psoriatic Arthritis Therapeutics Market Size (2016-2027)
9.2 Latin America Psoriatic Arthritis Therapeutics Market Size by Type
9.2.1 Latin America Psoriatic Arthritis Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Psoriatic Arthritis Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Psoriatic Arthritis Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Psoriatic Arthritis Therapeutics Market Size by Application
9.3.1 Latin America Psoriatic Arthritis Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Psoriatic Arthritis Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Psoriatic Arthritis Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Psoriatic Arthritis Therapeutics Market Size by Country
9.4.1 Latin America Psoriatic Arthritis Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Psoriatic Arthritis Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Psoriatic Arthritis Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Psoriatic Arthritis Therapeutics Market Size by Type
10.2.1 Middle East & Africa Psoriatic Arthritis Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Psoriatic Arthritis Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Psoriatic Arthritis Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Psoriatic Arthritis Therapeutics Market Size by Application
10.3.1 Middle East & Africa Psoriatic Arthritis Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Psoriatic Arthritis Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Psoriatic Arthritis Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Psoriatic Arthritis Therapeutics Market Size by Country
10.4.1 Middle East & Africa Psoriatic Arthritis Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Psoriatic Arthritis Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Psoriatic Arthritis Therapeutics Introduction
11.1.4 Pfizer Revenue in Psoriatic Arthritis Therapeutics Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Bayer
11.2.1 Bayer Company Details
11.2.2 Bayer Business Overview
11.2.3 Bayer Psoriatic Arthritis Therapeutics Introduction
11.2.4 Bayer Revenue in Psoriatic Arthritis Therapeutics Business (2016-2021)
11.2.5 Bayer Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Psoriatic Arthritis Therapeutics Introduction
11.3.4 Novartis Revenue in Psoriatic Arthritis Therapeutics Business (2016-2021)
11.3.5 Novartis Recent Development
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Company Details
11.4.2 Abbott Laboratories Business Overview
11.4.3 Abbott Laboratories Psoriatic Arthritis Therapeutics Introduction
11.4.4 Abbott Laboratories Revenue in Psoriatic Arthritis Therapeutics Business (2016-2021)
11.4.5 Abbott Laboratories Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Psoriatic Arthritis Therapeutics Introduction
11.5.4 Sanofi Revenue in Psoriatic Arthritis Therapeutics Business (2016-2021)
11.5.5 Sanofi Recent Development
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Company Details
11.6.2 Bristol-Myers Squibb Business Overview
11.6.3 Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Introduction
11.6.4 Bristol-Myers Squibb Revenue in Psoriatic Arthritis Therapeutics Business (2016-2021)
11.6.5 Bristol-Myers Squibb Recent Development
11.7 Janssen Biotech
11.7.1 Janssen Biotech Company Details
11.7.2 Janssen Biotech Business Overview
11.7.3 Janssen Biotech Psoriatic Arthritis Therapeutics Introduction
11.7.4 Janssen Biotech Revenue in Psoriatic Arthritis Therapeutics Business (2016-2021)
11.7.5 Janssen Biotech Recent Development
11.8 Amgen
11.8.1 Amgen Company Details
11.8.2 Amgen Business Overview
11.8.3 Amgen Psoriatic Arthritis Therapeutics Introduction
11.8.4 Amgen Revenue in Psoriatic Arthritis Therapeutics Business (2016-2021)
11.8.5 Amgen Recent Development
11.9 UCB
11.9.1 UCB Company Details
11.9.2 UCB Business Overview
11.9.3 UCB Psoriatic Arthritis Therapeutics Introduction
11.9.4 UCB Revenue in Psoriatic Arthritis Therapeutics Business (2016-2021)
11.9.5 UCB Recent Development
11.10 AbbVie
11.10.1 AbbVie Company Details
11.10.2 AbbVie Business Overview
11.10.3 AbbVie Psoriatic Arthritis Therapeutics Introduction
11.10.4 AbbVie Revenue in Psoriatic Arthritis Therapeutics Business (2016-2021)
11.10.5 AbbVie Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Psoriatic Arthritis Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Nonsteroidal Anti-Inflammatory Drug
Table 3. Key Players of Disease-Modifying Antirheumatic Drug
Table 4. Key Players of Biologic Drug
Table 5. Key Players of Enzyme Inhibitor
Table 6. Global Psoriatic Arthritis Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Psoriatic Arthritis Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Psoriatic Arthritis Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Psoriatic Arthritis Therapeutics Market Share by Regions (2016-2021)
Table 10. Global Psoriatic Arthritis Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Psoriatic Arthritis Therapeutics Market Share by Regions (2022-2027)
Table 12. Psoriatic Arthritis Therapeutics Market Trends
Table 13. Psoriatic Arthritis Therapeutics Market Drivers
Table 14. Psoriatic Arthritis Therapeutics Market Challenges
Table 15. Psoriatic Arthritis Therapeutics Market Restraints
Table 16. Global Psoriatic Arthritis Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Psoriatic Arthritis Therapeutics Market Share by Players (2016-2021)
Table 18. Global Top Psoriatic Arthritis Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Psoriatic Arthritis Therapeutics as of 2020)
Table 19. Ranking of Global Top Psoriatic Arthritis Therapeutics Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Psoriatic Arthritis Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Psoriatic Arthritis Therapeutics Product Solution and Service
Table 23. Date of Enter into Psoriatic Arthritis Therapeutics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Psoriatic Arthritis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Psoriatic Arthritis Therapeutics Revenue Market Share by Type (2016-2021)
Table 27. Global Psoriatic Arthritis Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Psoriatic Arthritis Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Psoriatic Arthritis Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Psoriatic Arthritis Therapeutics Revenue Market Share by Application (2016-2021)
Table 31. Global Psoriatic Arthritis Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Psoriatic Arthritis Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Psoriatic Arthritis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Psoriatic Arthritis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Psoriatic Arthritis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Psoriatic Arthritis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Psoriatic Arthritis Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Psoriatic Arthritis Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Psoriatic Arthritis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Psoriatic Arthritis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Psoriatic Arthritis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Psoriatic Arthritis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Psoriatic Arthritis Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Psoriatic Arthritis Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Psoriatic Arthritis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Psoriatic Arthritis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Psoriatic Arthritis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Psoriatic Arthritis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Psoriatic Arthritis Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Psoriatic Arthritis Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Psoriatic Arthritis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Psoriatic Arthritis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Psoriatic Arthritis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Psoriatic Arthritis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Psoriatic Arthritis Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Psoriatic Arthritis Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Psoriatic Arthritis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Psoriatic Arthritis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Psoriatic Arthritis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Psoriatic Arthritis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Psoriatic Arthritis Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Psoriatic Arthritis Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 63. Pfizer Company Details
Table 64. Pfizer Business Overview
Table 65. Pfizer Psoriatic Arthritis Therapeutics Product
Table 66. Pfizer Revenue in Psoriatic Arthritis Therapeutics Business (2016-2021) & (US$ Million)
Table 67. Pfizer Recent Development
Table 68. Bayer Company Details
Table 69. Bayer Business Overview
Table 70. Bayer Psoriatic Arthritis Therapeutics Product
Table 71. Bayer Revenue in Psoriatic Arthritis Therapeutics Business (2016-2021) & (US$ Million)
Table 72. Bayer Recent Development
Table 73. Novartis Company Details
Table 74. Novartis Business Overview
Table 75. Novartis Psoriatic Arthritis Therapeutics Product
Table 76. Novartis Revenue in Psoriatic Arthritis Therapeutics Business (2016-2021) & (US$ Million)
Table 77. Novartis Recent Development
Table 78. Abbott Laboratories Company Details
Table 79. Abbott Laboratories Business Overview
Table 80. Abbott Laboratories Psoriatic Arthritis Therapeutics Product
Table 81. Abbott Laboratories Revenue in Psoriatic Arthritis Therapeutics Business (2016-2021) & (US$ Million)
Table 82. Abbott Laboratories Recent Development
Table 83. Sanofi Company Details
Table 84. Sanofi Business Overview
Table 85. Sanofi Psoriatic Arthritis Therapeutics Product
Table 86. Sanofi Revenue in Psoriatic Arthritis Therapeutics Business (2016-2021) & (US$ Million)
Table 87. Sanofi Recent Development
Table 88. Bristol-Myers Squibb Company Details
Table 89. Bristol-Myers Squibb Business Overview
Table 90. Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Product
Table 91. Bristol-Myers Squibb Revenue in Psoriatic Arthritis Therapeutics Business (2016-2021) & (US$ Million)
Table 92. Bristol-Myers Squibb Recent Development
Table 93. Janssen Biotech Company Details
Table 94. Janssen Biotech Business Overview
Table 95. Janssen Biotech Psoriatic Arthritis Therapeutics Product
Table 96. Janssen Biotech Revenue in Psoriatic Arthritis Therapeutics Business (2016-2021) & (US$ Million)
Table 97. Janssen Biotech Recent Development
Table 98. Amgen Company Details
Table 99. Amgen Business Overview
Table 100. Amgen Revenue in Psoriatic Arthritis Therapeutics Business (2016-2021) & (US$ Million)
Table 101. Amgen Recent Development
Table 102. UCB Company Details
Table 103. UCB Business Overview
Table 104. UCB Psoriatic Arthritis Therapeutics Product
Table 105. UCB Revenue in Psoriatic Arthritis Therapeutics Business (2016-2021) & (US$ Million)
Table 106. UCB Recent Development
Table 107. AbbVie Company Details
Table 108. AbbVie Business Overview
Table 109. AbbVie Psoriatic Arthritis Therapeutics Product
Table 110. AbbVie Revenue in Psoriatic Arthritis Therapeutics Business (2016-2021) & (US$ Million)
Table 111. AbbVie Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Psoriatic Arthritis Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Nonsteroidal Anti-Inflammatory Drug Features
Figure 3. Disease-Modifying Antirheumatic Drug Features
Figure 4. Biologic Drug Features
Figure 5. Enzyme Inhibitor Features
Figure 6. Global Psoriatic Arthritis Therapeutics Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Research Labs Case Studies
Figure 10. Psoriatic Arthritis Therapeutics Report Years Considered
Figure 11. Global Psoriatic Arthritis Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Psoriatic Arthritis Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Psoriatic Arthritis Therapeutics Market Share by Regions: 2020 VS 2027
Figure 14. Global Psoriatic Arthritis Therapeutics Market Share by Regions (2022-2027)
Figure 15. Global Psoriatic Arthritis Therapeutics Market Share by Players in 2020
Figure 16. Global Top Psoriatic Arthritis Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Psoriatic Arthritis Therapeutics as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Psoriatic Arthritis Therapeutics Revenue in 2020
Figure 18. Global Psoriatic Arthritis Therapeutics Revenue Market Share by Type (2016-2021)
Figure 19. Global Psoriatic Arthritis Therapeutics Revenue Market Share by Type (2022-2027)
Figure 20. North America Psoriatic Arthritis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Psoriatic Arthritis Therapeutics Market Share by Type (2016-2027)
Figure 22. North America Psoriatic Arthritis Therapeutics Market Share by Application (2016-2027)
Figure 23. North America Psoriatic Arthritis Therapeutics Market Share by Country (2016-2027)
Figure 24. United States Psoriatic Arthritis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Psoriatic Arthritis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Psoriatic Arthritis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Psoriatic Arthritis Therapeutics Market Share by Type (2016-2027)
Figure 28. Europe Psoriatic Arthritis Therapeutics Market Share by Application (2016-2027)
Figure 29. Europe Psoriatic Arthritis Therapeutics Market Share by Country (2016-2027)
Figure 30. Germany Psoriatic Arthritis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Psoriatic Arthritis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Psoriatic Arthritis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Psoriatic Arthritis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Psoriatic Arthritis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Psoriatic Arthritis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Psoriatic Arthritis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Psoriatic Arthritis Therapeutics Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Psoriatic Arthritis Therapeutics Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Psoriatic Arthritis Therapeutics Market Share by Region (2016-2027)
Figure 40. China Psoriatic Arthritis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Psoriatic Arthritis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Psoriatic Arthritis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Psoriatic Arthritis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Psoriatic Arthritis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Psoriatic Arthritis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Psoriatic Arthritis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Psoriatic Arthritis Therapeutics Market Share by Type (2016-2027)
Figure 48. Latin America Psoriatic Arthritis Therapeutics Market Share by Application (2016-2027)
Figure 49. Latin America Psoriatic Arthritis Therapeutics Market Share by Country (2016-2027)
Figure 50. Mexico Psoriatic Arthritis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Psoriatic Arthritis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Psoriatic Arthritis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Psoriatic Arthritis Therapeutics Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Psoriatic Arthritis Therapeutics Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Psoriatic Arthritis Therapeutics Market Share by Country (2016-2027)
Figure 56. Turkey Psoriatic Arthritis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Psoriatic Arthritis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Psoriatic Arthritis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Pfizer Revenue Growth Rate in Psoriatic Arthritis Therapeutics Business (2016-2021)
Figure 60. Bayer Revenue Growth Rate in Psoriatic Arthritis Therapeutics Business (2016-2021)
Figure 61. Novartis Revenue Growth Rate in Psoriatic Arthritis Therapeutics Business (2016-2021)
Figure 62. Abbott Laboratories Revenue Growth Rate in Psoriatic Arthritis Therapeutics Business (2016-2021)
Figure 63. Sanofi Revenue Growth Rate in Psoriatic Arthritis Therapeutics Business (2016-2021)
Figure 64. Bristol-Myers Squibb Revenue Growth Rate in Psoriatic Arthritis Therapeutics Business (2016-2021)
Figure 65. Janssen Biotech Revenue Growth Rate in Psoriatic Arthritis Therapeutics Business (2016-2021)
Figure 66. Amgen Revenue Growth Rate in Psoriatic Arthritis Therapeutics Business (2016-2021)
Figure 67. UCB Revenue Growth Rate in Psoriatic Arthritis Therapeutics Business (2016-2021)
Figure 68. AbbVie Revenue Growth Rate in Psoriatic Arthritis Therapeutics Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

---